+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global Clinical Risk Grouping Solution Market by Product (Dashboard Analytics Solutions, Risk Reporting Solutions, Scorecards & Visualization Tools), Deployment Mode (Private Cloud, Public Cloud), End User - Forecast 2024-2030

  • PDF Icon

    Report

  • 198 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 4995154
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Clinical Risk Grouping Solution Market size was estimated at USD 925.17 million in 2023, USD 1,052.19 million in 2024, and is expected to grow at a CAGR of 13.82% to reach USD 2,289.95 million by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Clinical Risk Grouping Solution Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Clinical Risk Grouping Solution Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Clinical Risk Grouping Solution Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Conduent, Inc., Dynamic Healthcare Systems, Inc. by Reveleer, Evolent Health, HBI Solutions, Inc., Health Catalyst Inc., Johns Hopkins University, Lightbeam Health Solutions, LLC, Optum Inc. by UnitedHealth Group, and Perahealth, Inc.

Market Segmentation & Coverage

This research report categorizes the Clinical Risk Grouping Solution Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Dashboard Analytics Solutions
    • Risk Reporting Solutions
    • Scorecards & Visualization Tools
  • Deployment Mode
    • Private Cloud
    • Public Cloud
  • End User
    • Ambulatory Care Centers
    • Hospitals
    • Long-Term Care Centers
    • Payers
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

  1. What is the market size and forecast of the Clinical Risk Grouping Solution Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Clinical Risk Grouping Solution Market?
  3. What are the technology trends and regulatory frameworks in the Clinical Risk Grouping Solution Market?
  4. What is the market share of the leading vendors in the Clinical Risk Grouping Solution Market?
  5. Which modes and strategic moves are suitable for entering the Clinical Risk Grouping Solution Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Clinical Risk Grouping Solution Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing focus on patient’s risk management
5.1.1.2. Implementation of big data in the healthcare industry to transform clinical outcomes
5.1.1.3. Advantages of risk management solutions
5.1.2. Restraints
5.1.2.1. Lack of infrastructure coupled with capital intensive clinical solutions
5.1.3. Opportunities
5.1.3.1. Increasing focus on AI and machine learning
5.1.3.2. Adoption of recording and maintaining the health records
5.1.3.3. Increasing physician burnout due to documentation needs
5.1.4. Challenges
5.1.4.1. Patient data privacy concerns
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Clinical Risk Grouping Solution Market, by Product
6.1. Introduction
6.2. Dashboard Analytics Solutions
6.3. Risk Reporting Solutions
6.4. Scorecards & Visualization Tools
7. Clinical Risk Grouping Solution Market, by Deployment Mode
7.1. Introduction
7.2. Private Cloud
7.3. Public Cloud
8. Clinical Risk Grouping Solution Market, by End User
8.1. Introduction
8.2. Ambulatory Care Centers
8.3. Hospitals
8.4. Long-Term Care Centers
8.5. Payers
9. Americas Clinical Risk Grouping Solution Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Clinical Risk Grouping Solution Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Clinical Risk Grouping Solution Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. 3M Company
13.1.2. Conduent, Inc.
13.1.3. Dynamic Healthcare Systems, Inc. by Reveleer
13.1.4. Evolent Health
13.1.5. HBI Solutions, Inc.
13.1.6. Health Catalyst Inc.
13.1.7. Johns Hopkins University
13.1.8. Lightbeam Health Solutions, LLC
13.1.9. Optum Inc. by UnitedHealth Group
13.1.10. Perahealth, Inc.
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. CLINICAL RISK GROUPING SOLUTION MARKET RESEARCH PROCESS
FIGURE 2. CLINICAL RISK GROUPING SOLUTION MARKET SIZE, 2023 VS 2030
FIGURE 3. CLINICAL RISK GROUPING SOLUTION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. CLINICAL RISK GROUPING SOLUTION MARKET DYNAMICS
FIGURE 7. CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2023 VS 2030 (%)
FIGURE 10. CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 12. CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. CLINICAL RISK GROUPING SOLUTION MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. CLINICAL RISK GROUPING SOLUTION MARKET SHARE, BY KEY PLAYER, 2023

Companies Mentioned

  • 3M Company
  • Conduent, Inc.
  • Dynamic Healthcare Systems, Inc. by Reveleer
  • Evolent Health
  • HBI Solutions, Inc.
  • Health Catalyst Inc.
  • Johns Hopkins University
  • Lightbeam Health Solutions, LLC
  • Optum Inc. by UnitedHealth Group
  • Perahealth, Inc.

Methodology

Loading
LOADING...

Table Information